Clinical Trials Directory

Trials / Completed

CompletedNCT00348335

Efficacy of Topical Cyclosporin for Ocular Rosacea

Efficacy of Topical Cyclosporin 0.05% for the Treatment of Ocular Rosacea

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
35 (actual)
Sponsor
Ophthalmic Consultants of Long Island · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine whether Restasis (topical cyclosporin) is effective in the treatment of ocular rosacea

Detailed description

The study is designed to compare the efficacy of topical cyclosporin (Restasis) with that of Refresh Endura for the treatment of the signs and symptoms of ocular rosacea in patients presently controlled on topical corticosteroids

Conditions

Interventions

TypeNameDescription
DRUGCyclosporine 0.05%
DRUGOcular lubricant

Timeline

Start date
2006-06-01
Primary completion
2007-09-01
Completion
2007-09-01
First posted
2006-07-04
Last updated
2011-07-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00348335. Inclusion in this directory is not an endorsement.